CLINICAL AND DIAGNOSTIC VALUE OF PROCALCITONIN LEVELS IN VICTIMS OF SEVERE CONCOMITANT INJURY

Mortality due to pyoseptic complications after severe mechanical injury is rather high. Some hopes for its reduction are associated with the timely detection of infectious complications. In this case an important role is, in terms of early diagnosis, attached to the calcitonin prohormone procalcitonin that is positioned itself as a marker for the progression of a bacterial infectious process. At the same time, there is evidence for elevated PCT levels after extensive surgical interventions and in massive injuries directly unassociated with the development of an infectious process. Objective: to estimate the significance of its changes early after injury. A prospective investigation was conducted, which enrolled 76 victims of severe concomitant mechanical injury (patients with severe brain injury and victims whose death had occurred within the following few days were excluded from the study). The time course of changes in the blood levels of PCT, C-reactive protein, activated monocytes expressing receptors for lipopolysaccharide and other bacterial antigens (CD14+ and HLA-R+), cytokines (IL-6, IL-10), glucose, and lactate was studied on admission, at 12 and 24 hours, 3, 7, and 10 days. The diagnosis of bacteremia involved blood microbiology tests for sterility and polymerase chain reaction to detect antigens of blood opportunistic microorganisms. The findings were analyzed in view of injury severity scores (ISS), the development of infectious complications, and an outcome. PCT concentrations were shown to rise significantly within the first 24 hours after injury in the absence of clinical manifestations of infectious complications. The increase in PCT levels was preceded by the highest rise of HLA-DR+ within the first 24 hours and CD14+ just 12 hours after injury, which could not preclude the bacterial translocation inducing, along with other factors, the development of a systemic inflammatory response. At the same time, the findings could suggest that the role of this indicator must not boil down exclusively to the function of that of infectious complications.

1. Политравма: травматическая болезнь, дисфункция иммунной системы, современная стратегия лечения / под ред. Е. К. Гуманенко и В. К. Козлова. - М.: ГЭОЕФЗ-Медиа, 2008. - 608 с.

2. Полушин Ю. С., Афанасьев А. А., Пивоварова Л. П. и др. Секреторный иммуноглобулин А (sIgA) как маркёр бактериальной транслокации при тяжёлой сочетанной травме // Вестник анестезиол. и реаниматол. - 2014. - № 6. - С. 51-58.

3. Bistrian B. R. Acute phase proteins and the systemic inflammatory response // Crit. Care Med. - 1999. - Vol. 27, № 3. - P. 452-453.

4. Dandona P., Nix D., Wilson M. F. Procalcitonin increase after endotoxin injection in normal subjects // J. Clin. Endocrinol. Metab. - 1994. - Vol. 79, № 6. - P. 1605-1608.

5. Giannoudis P., Smith R. M., Evans R. T. Serum CRP and IL-6 levels after trauma: not predictive of septic complications // Acta Orthop. Scand. - 1998. - № 69. - Р. 184-188.

6. Karzai W., Oberhoffer M., Meier-Hellmann A. et al. Procalcitonin - a new indicator of systemic response to severe infection // Infection. - 1997. - Vol. 25. № 6. - P. 329-334.

7. Le J., Vilcek J. Interleukin-6: a multifunctional cytokine regulating immune reactions and the acute phase protein response // Lab. Invest. - 1989. - № 61. - Р. 588-602.

8. Meisner M., Adina H., Schmidt J. Correlation of procalcitonin and C-reactive protein to inflammation, complications and outcome during the intensive care unit course of multiple-trauma patients // Crit. Care. - 2006. - Vol. 10, № 1. - Р. 1.

9. Oberhoffer M., Bigel D., Meier-Hellmann A. Procalcitonin is immunological markers in infection inflammation // Brit. J. Anaesth. - 1996. - Vol. 76. - Р. 352.

10. Nylen E. S., Snider R. H., Thompson K. A. Pneumonitis-associated hyperprocalcitoninemia // Amer. J. Med. Sci. - 1996. - Vol. 312, № 1. - P. 12-18.

11. Pierre E., Sylvain L., Serge A. Serum PCT elevation in critically ill patients at the onset of bacteremia caused by either gram-negative or gram-positive bacteria // BMC. Infect. Dis. -2008. - Vol. 8. - P. 38-39.

12. Quenot J.-P., Luyt C.-E., Roche N. et al. Role of biomarkers in the management of antibiotic therapy: an expert panel review II: clinical use of biomarkers for initiation or discontinuation of antibiotic therapy // An. Intens. Care. - 2013. - № 3. - P. 21.

13. Russwurms S., Wiederhold W., Oberhoffer M. et al. Procalcitonin as monocyte marker for early diagnosis in septic abortus [in German] // Z. Geburtsh Neonatol. - 1999. - № 14. - P. 29-33.

14. Schuetz Р., Matthias B., Christ-Crain M. et al. Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis // Clin. Infect. Dis. - 2012. - № 55. - P. 651-662.

15. Schuetzn P., Maurer P., Punjabi V. et al. Procalcitonin decrease over 72 hours in US critical care units predicts fatal outcome in sepsis patients // Crit. Care. - 2013. - № 17. - P. 115.

16. Soni N., Samson D., Galaydick J. L. Procalcitonin-guided antibiotic therapy: a systematic review and meta-analysis // J. Hosp. Med. - 2013. - № 9. - Р. 530-540.

17. Wicher J., Bienvenu J., Monneret G. Procalcitonin as an acute phase marker // Ann. Clin. Biochem. - 2001. - Vol. 38. - P. 483-493.

18. Uzzan B., Cohen R., Nicolas P. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis // Crit. Care Med. - 2006. - Vol. 34, № 7.

19. Zelzer S., Aigner R. M., Khoschsorur G. et al. Comparative study of the immunological marker IL-6 and the non-immunological marker PCT in surgery patients with infections and multiple trauma // Open Pathol. J. - 2009. - № 3. - P. 124-130.